SCHEMBL1003546

SCHEMBL1003546

CCC[C@H](N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL352611 1.00
SCHEMBL214301 1.00
Water SCHEMBL8212960 0.97
Hydrochloric Acid SCHEMBL1864650 0.97
Hydrochloric Acid SCHEMBL1861619 0.97
Hydrochloric Acid SCHEMBL1861313 0.97
SCHEMBL29421382 0.97
Alcohol SCHEMBL8668911 0.97 TSHR (0.46)
Sulfuric Acid SCHEMBL21552194 0.87 TP53 (0.48)
SCHEMBL29020431 0.85 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025133248-A1 DIASTEREOMERIC AMINOALCOHOL AND AMINOETHER SALTS OF 2-[(4R,S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-3,4-DIHYDROQUINAZOLIN-4-YL]ACETIC ACID AND THEIR USE FOR ENANTIOMERIC SEPARATION AIC246 AG & CO. KG (DE) 2025-06-26 WO claimed
US-9932335-B2 Pyrrolopyridine or pyrazolopyridine derivatives HOFFMANN-LA ROCHE INC. (US) 2018-04-03 US claimed
US-9833768-B2 Affinity reagents for protein purification IMPOSSIBLE FOODS INC. (US) 2017-12-05 US claimed
US-20170320041-A1 AFFINITY REAGENTS FOR PROTEIN PURIFICATION IMPOSSIBLE FOODS INC. 2017-11-09 US claimed
US-9737875-B2 Affinity reagents for protein purification IMPOSSIBLE FOODS INC. (US) 2017-08-22 US claimed
CN-104620104-B Affinity Reagents for Protein Purification 非凡食品有限公司 2017-03-01 CN claimed
US-20160194321-A1 PYRROLOPYRIDINE OR PYRAZOLOPYRIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2016-07-07 US claimed
US-12377100-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2025-08-05 US disclosed
WO-2025133248-A1 DIASTEREOMERIC AMINOALCOHOL AND AMINOETHER SALTS OF 2-[(4R,S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-3,4-DIHYDROQUINAZOLIN-4-YL]ACETIC ACID AND THEIR USE FOR ENANTIOMERIC SEPARATION AIC246 AG & CO. KG (DE) 2025-06-26 WO disclosed
US-20250195524-A1 PYRIMIDO-PYRIDAZINONE COMPOUND AS TOLL-LIKE RECEPTOR AGONIST SHANGHAI VISONPHARMA CO., LTD. (CN) 2025-06-19 US disclosed
CN-119306633-B Beta-form3Method for synthesizing amino acid derivatives 深圳市第二人民医院(深圳市转化医学研究院) 2025-04-25 CN disclosed
US-20250059183-A1 PYRIDINE[4,3-D]PYRIMIDINE COMPOUND AS TLR7/8 AGONIST SHANGHAI VISONPHARMA CO., LTD. (CN) 2025-02-20 US disclosed
EP-4497752-A1 PYRIMIDO-PYRIDAZINONE COMPOUND AS TOLL-LIKE RECEPTOR AGONIST Shanghai Visonpharma Co., Ltd. (CN) 2025-01-29 EP disclosed
WO-2005042464-A1 ANDROGEN RECEPTOR MODULATORS KARO BIO AB (SE) 2005-05-12 WO disclosed
EP-1455741-A2 NOVEL DEVELOPER COMPONENTS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-09-15 EP disclosed
US-20040142999-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2004-07-22 US disclosed
CN-1512983-A Compounds and compositions as cathepsins inhibitors AXYSҩ�﹫˾ 2004-07-14 CN disclosed
WO-2003053370-A2 NOVEL DEVELOPER COMPONENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-07-03 WO disclosed
WO-2000064904-A1 5,7-BICYCLIC AMIDINE DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS ASTRAZENECA AB (SE) 2000-11-02 WO disclosed
EP-0520336-A2 Aldehyde derivatives and their use as calpain inhibitors FUJIREBIO Inc. (JP) 1992-12-30 EP disclosed